risks of direct oral anticoagulants
Published 1 year ago • 123 plays • Length 6:51Download video MP4
Download video MP3
Similar videos
-
51:46
effectiveness and safety of direct oral anticoagulants vs warfarin in patients with valvular afib
-
3:22
risk factors for oral anticoagulant-associated ich
-
3:33
direct oral anticoagulants have minimal risk of delayed intracranial hemorrhage
-
34:25
reversal agents for direct oral anticoagulants for patients experiencing intracerebral haemorrhage
-
4:07
direct oral anticoagulants (doacs) and the impact of 'antidotes' - cardioed lecture
-
7:55
reversal of direct oral anticoagulants
-
5:24
direct oral anticoagulants - information about how to take your medication safely
-
10:27
direct oral anticoagulants: an introduction
-
3:57
drug monitoring and reversal agents for direct oral anticoagulants
-
4:30
differentiation of direct oral anticoagulants for nvaf
-
3:28
novel oral anticoagulants: risk score for major bleeding
-
6:04
differentiation of direct oral anticoagulants for nonvalvular atrial fibrillation
-
58:23
direct oral anticoagulants versus warfarin
-
4:10
esc 2015: assessing risk of bleeding in patients who require new oral anticoagulants
-
12:05
direct oral anticoagulants: reversal strategies for doacs & laboratory role
-
5:36
reversal agents for direct oral anticoagulants
-
4:29
marco proietti, ehra 2018 – the risk of oral anticoagulants and nsaids
-
15:13
direct oral anticoagulants: impact & interference of doacs on coagulation testing
-
3:40
reversal agents for the management of oral anticoagulant-associated ich